Compare Nike Inc (NKE) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nike Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Nike Inc trades at $34.8 (market cap $51.60B), while Royalty Pharma plc Class A Ordinary Shares trades at $57.06 (market cap $25.27B). The key difference: Nike Inc is far larger — about 2× Royalty Pharma plc Class A Ordinary Shares's market cap, and Nike Inc pays the higher dividend (4.72%). Which is the better fit depends on your goals — on Pluang, investors hold Nike Inc for 155 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| NKE | RPRX | |
|---|---|---|
Market Cap | $51.60B | $25.27B |
Volume | 43,506,062 | 3,671,183 |
Sector | Consumer Cyclical | Health |
52-Week High | $69.68 | $63.96 |
52-Week Low | $33.87 | $35.44 |
Typical Hold Time | 155 Days | 1 Days |
Enterprise Value | $54.30B | $32.50B |
Dividend Yield | 4.72% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nike's stock trades at $34.36, down 0.72% with a bearish technical outlook. The company reported $46.31B in revenue for 2025 with a 6.74% net margin, though earnings have beaten expectations in recent quarters. Analyst consensus remains positive with a $36.98 price target, while recent news highlights challenges in China and inventory management.
Nike faces near-term headwinds from slowing revenue growth and margin pressure, but strong brand positioning and consistent earnings beats provide upside potential. Key risks include consumer demand weakness and competitive pressures, while institutional sentiment remains cautiously optimistic for a turnaround.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nike Inc
NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.
Read more on NKE →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
